A carregar...
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study
BACKGROUND: Crohn's disease (CD) and multiple sclerosis (MS) share common pathogenic processes. Interferon (IFN) beta-1a is effective and generally well tolerated in patients with MS and has been shown to down-regulate the expression of interleukin-12, a cytokine that is thought to be involved...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2674451/ https://ncbi.nlm.nih.gov/pubmed/19302707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-9-22 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|